Company / SG&A Expense
SS Innovations International, Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$14.8M
FY2025
5-year range
$458.8K / $14.8M
FY2021-FY2025
Trend
+47.5%
vs FY2024
Sector context
#157 of 158
Health Care
What the data says
Among 158 Health Care companies, SS Innovations International, Inc. is in the top 1% for sg&a expense. SG&A Expense has fluctuated over the past 10 years, ranging from $287,737 in FY2020 to $15M in FY2025.
Based on SEC 10-K filings.
$15M in FY2025 with a 5-year CAGR of +120.1%.
Increased from $10M to $15M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +65.9%
- 5-Year CAGR
- +120.1%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 158This company $14.8M Sector average $175.9B
▼
-100.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +120.1%, indicating consistent growth.
- In FY2025, sg&a expense increased 47.5% year-over-year.
- Ranks #157 out of 158 companies in the Health Care sector.
- Lowest sg&a expense in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.26 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.8M | +47.5% |
| FY2024 | $10.1M | +0.0% |
| FY2023 | $10.1M | +209.5% |
| FY2022 | $3.3M | +608.8% |
| FY2021 | $458.8K | +59.5% |
| FY2020 | $287.7K | -61.7% |
| FY2019 | $752.0K | +86.1% |
| FY2018 | $404.2K | -57.0% |
| FY2017 | $939.6K | +180.6% |
| FY2016 | $334.9K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026